[ET Net News Agency, 11 May 2026] INNOGEN-B (02591) rose 28.4% to HK$16.24.
It hits an intra-day high of HK$16.49, breaking above the 10-D SMA of HK$14.478, and an intra-day low of HK$12.6. The total shares traded was 5.38 million, with a value of HK$77.45m. The active buy/sell ratio is 65:35, with net buying turnover of HK$21.52m. CHINA INV INFO accounts for greatest net responsive buying turnover of HK$1.26m, with volume weighted average price of HK$14.827. USMART SEC accounts for greatest net responsive selling turnover of HK$3.87m, with volume weighted average price of HK$12.984. The stock has risen a combined 30.1% over the past 2 consecutive trading days.
Basic Information| Nominal | 16.240 | % Chg | +28.38% |
| High | 16.490 | Low | 12.600 |
| Shares Tr | 5.38m | Turnover | 77.45m |
| 10-D SMA | 14.478 | %H.V | 78.332 |
| 20-D SMA | 16.874 | VWAP | 14.388 |
| 50-D SMA | 20.380 | RSI14 | 45.401 |
Status: Breaking above the 10-D SMA, active buy/sell ratio is 65:35, with net buying turnover of HK$21.52m, rising a combined 30.1% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| INNOGEN-B (02591) | 16.24 | +28.38 |
| INNOVENT BIO (01801) | 88.05 | -2.17 |
| XTALPI (02228) | 9.02 | -1.31 |
| WUXI XDC (02268) | 54.70 | -2.32 |
| WUXI BIO (02269) | 32.44 | -0.67 |
| TRANSTHERA-B (02617) | 53.60 | -2.90 |
| BAO PHARMA-B (02659) | 26.80 | -2.19 |
| BEONE MEDICINES (06160) | 186.30 | -2.26 |
| AKESO (09926) | 131.40 | -1.94 |
| REMEGEN (09995) | 96.25 | -1.48 |
(ed)
Nominal 
